Member Info for BeContrarian

Trek I think it’s because they plan on releasing market sensitive info at the presentation…

Nigel, for what it’s worth, I thought you were treated a little harshly yesterday. However, you’re now starting to come across as a bit of a jilted lover, very much inviting further criticism.
In the nicest possible way, give it a rest pal.

Whichever way I cut it I cannot see us staying in a range as Woodstock suggests. Massive inflection point coming up here and so either sticky hands force a steady run up, or there will be a coordinated effort to spook and force a drop just prior to news (as happened before).

I’ll be keeping some funds in reserve for the latter scenario.

Andy you keep mention certain posters getting stung, what do you mean by that? Please elaborate? Thanks

Great research Andybe4, thanks. A timely reminder that it’s David vs Goliath and the scientific community is not as objective as many would believe. Hold for results!

Let’s hope SNG wipes out your losses!

Strictly that was a duff move! It was so obvious OO was deeply oversold. You literally hit sell at the capitulation point, d’oh!

Signs are all there ladies and gents, massive volume in spite of a criminal 5%+ spread on average. Think we’ve turned the corner *touches wood*

Might not be any news. 16.5 was probably capitulation and let’s hope that background seller has finished.

I would urge caution on the RNS, all they ever do here is invite selling pressure it seems.

The price is correcting on its own. Id like to see where the natural price action leads before an RNS supercharges it

I understand your sentiment Andybe4 but it doesn’t need pumping prior to results. In time true value will assert itself. I agree that compared to most US biotech SNG is laughably undervalued. But it also speaks of our general mindset here in the UK vs the investment habits of the US.

We don’t need to turn SNG into a casino in the run up to results. Leave it be and watch the fireworks come results. No use trying to pump it now.

Patience is key as you say Nano. Never fails to surprise me the impatience of some. SNG, another stock I’m in, news imminent within the next 30 days that could see it 5 bag instantly, and yet it gets sold into. Beggars belief!

Just some general points worthy of consideration:
- we simply won’t know how bad omicron is until the current wave is about a month old, then we will have a better handle on hospitalisation rates etc. Anecdotal evidence isn’t really useful to be honest, just because Dr so and so says anecdotally hospitals are quiet is like saying there won’t be a hurricane tomorrow because it’s sunny right now. Anyone pretending to know how ‘bad’ this variant is, one way or another, is taking out their rear end.
- a milder virus with increased transmissibility is still potentially just as dangerous due to the rate of spread. Law of averages tells you even if % of those with it are hospitalised is lower, the higher % of population infected counteracts that. A mild virus could still overwhelm hospitals due to sheer volume of infections.
- the omicron mutations prove that mutation is, and will continue, to happen. As a world community the limitations of vaccines are beginning to show. The fact governments are doubling down on vaccines, despite massive concerns about vaccine efficacy in the face of this variant shows you how desperate the situation must be, and that’s amongst developed nations with far more means and money to do something about an outbreak.
- the idea that viruses only ever mutate to become less deadly is dangerous hogwash. People espousing this view need to educate themselves: https://www.google.co.uk/amp/s/amp.usatoday.com/amp/7839167002
So overall, it looks to me like we are back to square 1. The space is primed for a great therapeutic.

Good points Andy and NDN. As I’ve said before, price targets are really for traders, not PIs. One must take their cues from the narrative. So it hits that golden £10 mark that so many talk about and orders are flying in left right and centre, you still sell?

My own personal take is that once results drop I’ll be waiting and seeing. I can’t see good results not meeting with a flurry of orders so I’ll be staying out for at least a little while just to see where we end up.

Jim, briefly took you off filter to see what possible explanation you could give for sharing CF’s number.

So the CEO, in his concern for an investor and their worries, offers his personal mobile number for a chat, and all you can do is share it here and STILL dig the guy out despite not having the guts to call him. What person in their right mind would do that when presented with a golden opportunity like that? How many CEO’s would go to such lengths to allay investor fears?

What a spineless, toxic disgrace you are Jim. Shame on you. You deserve banning for sharing his number and betraying trust like that.

If that’s what he did then surely what goes for one must go for another?

Mark Green deposition a week today. Would appreciate the thoughts of the legally minded on here as to how important this could be? Thank you

At least Ryan took heed and actually served his ban.

I fear the hydra that is Bronx/Jim would soon be back to spew his daily bile under another monicker. Jeez what a life he must lead…

If P3 is a success there might be some profit taking but most switched on PIs will be sitting on hands. The landscape will change very quickly, orders will flood in. The usual supply and demand dynamics are not in play here, when your product is a matter of life and death the global demand will be very very high.

Whilst selling on results seems logical enough, it seems madness to me because surely the party is only just getting started?!

Pfizer’s pill added far more than 9 billion…